AJNS

NEUROEPIDEMIOLOGY / NEUROEPIDEMIOLOGIE
 
THE VALIDITY OF FILTER PAPER BLOOD SAMPLING FOR THE DETECTION OF HTLV-I SEROPOSITIVITY: A BENIN STUDY

EVALUATION DE LA LA POSSIBILITÉ DE DÉTECTION DES ANTICORPS HTLV-1 SUR DU SANG COLLECTÉ SUR PAPIER FILTRE: UNE ETUDE BENINOISE


  1. Institut d’Epidémiologie Neurologique et de Neurologie Tropicale, Limoges, France

E-Mail Contact - PREUX Pierre-Marie : preux (at) unilim (dot) fr


ABSTRACT

Screening for HTLV-I requires a venous blood sampling, which can be difficult during large scale epidemiologic surveys. The aim of this study was to assess the ability to detect antibodies to HTLV- 1 from blood collected on filter paper. This study was conducted in Benin and comprised of 109 subjects. The sensitivity of the method was 81%. The specificity was 100%. Concordance between serologic testing for HTLV-I by venipuncture as compared with collection on filter paper was poor. Other kits must be tested to evaluate if structural or functional differences diagnostic kits may explain this lack of sensitivity.

Keywords: Africa, Benin, HTLV-l,Filter paper, Benin, Africa, epidemiology, Evaluation


RESUME

Le depistage d’HTLV-l requiert un prélèvement de sang veineux, ce qui pent être difficile dans le déroulement d’études épidémiologiques a large échelle. Le but de cette étude était d’évaluer.la possibilité de détecter des anticorps centré HTLV-1 sur du sang collecté sur papier filtre. Cette etude a été conduite au Bénin et incluait 109 sujets. La sensibilité de la méthode était de 81%. Sa spécificité était de 100%. La concordance entre les sérologies réalisées sur du sang veineux et celles réalisées sur papier filtre était mauvaise. D’autres kits devaient être testeés afin d’évaluer si des differences structurelles ou fonctionnelles entre ces kits de dépistage peuvent expliquer ce .manque de sensibilité.

Mots clés : Afrique, Benin, HTLV1, Evaluation, Epidémiologie, Papier filtre

INTRODUCTION

Screening for HTLV-I requires a venous blood sampling, which can have certain drawbacks during large-scale epidemiologic surveys. Our aim was to assess the ability to detect antibodies to HTLV-I from blood collected on filter paper, a more convenient method that is already in use and has been validated in screening for the human immunodeficieney virus (HIV) [1]. A previous study was conducted by our team in Burundi and showed that the agreement between the two sampling methods to detect the seropositivity for HTLV-I was poor [2]. In order to assess this method on a higher number of patients, the present study was conducted in Benin in March 1995 where a cohort of HTLV-I positive subjects is surveyed since 1991 [3].

The study group was comprised of 109 subjects. Paired specimens were obtained: 10 ml of blood by venipuncture, and capillary blood obtained by lancet finger puncture which provided three blood spots, each I cm indiameter on chromatography paper (Whatman 311, Polylabo). The filter paper was let to dry in ambient air and then kept in a refrigerator at 40 Celsius in an air-tight container with desiccant. The biological analysis were performed within three weeks in Limoges (France) in the same laboratory without patient identification. Serologic testing for HTLV-I was performed using the same diagnostic kits for the serum and filter paper (screening with ELISA technique-HTLV-1/11, Abbott Laboratories, Chicago, USA-and confirmation of the samples considered positive using a Western Blot assay - Bioptim 2.3, Diagnostic Biotechnology, Singapore-). A 5mm diammeter punch from a filter paper spot of capillary blood was obtained and eluted in 200 microliters of the diluent supplied with the kit over a 12 hours period preceding the serologic testing. The tests were performed on the eluate thus obtained. Criteria for HTLV-I seropositivity were lhe recognition of two different proteins: gag (pl9 and/or p24) and env (gp46 and/or rgp21) [4].

The sensitivity of the method was 81% (Table 1). The specificity was 100%.

HTLV-I: Human T cell Leukemia Virus type 1; WB: Western Blot; ELISA: Enzyme Linked ImmunoSorbentAssay.

Concordance between serologic testing for HTLV-1 by venipuncture as compared with collection on filter paper was poor. The latter technique has the disadvantage of global decrease in sensitivity. These results do not confirm those by Jeannel et al. [5] who found complete concordance between the two serologic testing methods for HTLV during a study conducted in Zaire in 122 subjects. However, details on the sampling method used by these authors and the number of seropositive subjects in their study were not given.

Compared to our previous study in Burundi [2] carried out with a smaller sample of positive subjects, the sensitivity of filter paper has increased from 66.7% to 81.0%. Difference in the methods of conversation of the samples could explain this improvement (shorter delay to perform biological analysis; filter papers kept in a refrigerator). However, this sensitivity is still too low for screening purposes. To evaluate if structural or functional differences between diagnostic kits may explain this lack of sensitivity, other kits must be tested. It may be also be useful to assess antibodies stability under various conditions, particularly climatic.

Table 1: Serologic testing for HTLV-I using filter paper and serum after confirmation by WB in subjects that tested positive by ELISA in 109 subjects, Benin. March 1995.

Sera + - Indeterminate Total
Filter Papers
+ 30 0 2 32
- 7 68 2 77
Total 37 68 4 109

REFERENCES

  1. FORTES P, MENITOVE J, ROSS A ET AL:Evaluation of blood collected on filter paper for detection of antibodies to Human Immunodeficiency Virus Type I. J Clin Microbiol 1989;27:1380-1381.
  2. PREUX PM, NZISABIRA L, BONIS J ET AL.: The validity of filter paper blood sampling for the detection of HTLV-l seropositivity. NeurolInfEpidemiol 1996;1:51-56.
  3. HOUINATO D, VERDIER M, PREUX PM ET AL.:Intrafamilial clustering and 4-year follow-up of asymptomatic human T-cell leukaemia virus type I (HTLV-1) infection in Benin (West Africa). Int J Epidemiol 1998;7:146-152
  4. Centers for Diseases Control (CDC).: Update: serologic testing for Human T- Lymphotropic Vims Type I, United States1989 and 1990. MMWR 1992;41: 259-262.
  5. JEANNEL D, GARIN B, KAZADI K, ET AL.:The risk of Tropical Spastic Paraparesis differs according to ethnic group among HTLV-I carriers in Inongo, Zaire. JAIDS 1993,6:840-844.


© 2002-2012 African Journal of Neurological Sciences.
All rights reserved. Terms of use.
Tous droits réservés. Termes d'Utilisation.
ISSN: 1992-2647